Back

Improved long-term outcome in catheter ablation of atrial fibrillation: data from the Swedish national catheter ablation registry

20 March 2018 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Atrial fibrillation ablation - Multicenter studies and registries Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Niklas Hoglund

Umea University Hospital, Umea (Sweden)

7 More presentations in this session

Presentation thumbnail
Uninterrupted Direct Oral Anticoagulant therapy is an efficacious and safer alternative to Vitamin K Antagonists in patients undergoing catheter ablation for atrial fibrillation. A meta-analysis
Mr M. Ottoffy (Pecs, HU)
Abstract
Presentation thumbnail
Ablation Strategies for different types of atrial fibrillation in Europe - Results of the EORP Atrial Fibrillation Ablation Long-Term Registry
Doctor B. Schmidt (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
No support for additional left atrial substrate modification among patients with persistent atrial fibrillation at first PVI procedure- Results from German Ablation registry
Doctor C. Jilek (Munich, DE)
Abstract Slides
Presentation thumbnail
Markedly reduced fluoroscopy time in catheter ablation: data from the Swedish national catheter ablation registry
Doctor M. Ringborn (Karlskrona, SE)
Abstract Slides
Presentation thumbnail
Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicenter LAGO-AF Study
Doctor F. Bisbal (Barcelona, ES)
Abstract Slides

Access the full session

Session thumbnail
Atrial fibrillation ablation - Multicenter studies and registries

The Event

Event poster

EHRA 2018

20 March 2018 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources